Arrieta VA, Duerinck J, Burdett KB, Habashy KJ, et al. ERK1/2 Phosphorylation Predicts Survival in Recurrent Glioblastoma Following Intracerebral and Adjuvant PD-1/CTLA-4 Immunotherapy: A REMARK-Guided Analysis. Clin Cancer Res 2023 Nov 8. doi: 10.1158/1078-0432.CCR-23-1889.
PMID: 37939133